Filters

NFKBIB, 1-356aa , Human, His tag, E.coli

NFKBIB, 1-356aa , Human, His tag, E.coli size: bulk 0

Supplier GENWAYS BULK
Price 0
Size bulk
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Available sizes100ug:330, 500ug:990
Storestore in freezer for long therm or fridge for short time storage
Category Coli rec, ELISAs, e, human proteins, research antibodies
Conjugationhistidine
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene target 1-356aa , E, His tag, NFKBIB, coli
Short name 1-356aa , E, His tag, NFKBIB, coli
HostEscherichia coli
LabelHis
Species Humans, Human
Alternative name 1-356aa , Escherichia Coli, H, b, histidine detection labelled, sapiens, nuclear factor on kappa light polypeptide gene enhancer in B-cells inhibitor
Alternative techniqueescherichia
Alternative to gene target DNA-templated and biological process this GO :0007165 and signal transduction and biological process this GO :0032481 and positive regulation of type I interferon production and biological process this GO :0034134 and toll-like receptor 2 signaling pathway and biological process this GO :0034138 and toll-like receptor 3 signaling pathway and biological process this GO :0034142 and toll-like receptor 4 signaling pathway and biological process this GO :0034146 and toll-like receptor 5 signaling pathway and biological process this GO :0034162 and toll-like receptor 9 signaling pathway and biological process this GO :0034166 and toll-like receptor 10 signaling pathway and biological process this GO :0035666 and TRIF-dependent toll-like receptor signaling pathway and biological process this GO :0038123 and toll-like receptor TLR1:TLR2 signaling pathway and biological process this GO :0038124 and toll-like receptor TLR6:TLR2 signaling pathway and biological process this GO :0045087 and innate immune response and biological process this GO :0051092 and positive regulation of NF-kappaB transcription factor activity and biological process, IKBB and TRIP9, NFKBIB and IDBG-49787 and ENSG00000104825 and 4793, NFKBIB and IDBG-637425 and ENSBTAG00000001778 and 525408, Nfkbib and IDBG-164189 and ENSMUSG00000030595 and 18036, beta, nuclei, protein binding, this GO :0002224 and toll-like receptor signaling pathway and biological process this GO :0002755 and MyD88-dependent toll-like receptor signaling pathway and biological process this GO :0002756 and MyD88-independent toll-like receptor signaling pathway and biological process this GO :0003713 and transcription coactivator activity and molecular function this GO :0004871 and signal transducer activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005829 and cytosol and cellular component this GO :0006351 and transcription, this GO :0003713: transcription coactivator activity, this GO :0003713: transcription coactivator activity and also this GO :0004871: signal transducer activity and also this GO :0005515: protein binding, this GO :0004871: signal transducer activity, this GO :0005515: protein binding, nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor
Identity 7798
Gene NFKBIB
Long gene name NFKB inhibitor beta
Synonyms gene name beta , nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor
Synonyms IKBB TRIP9
Synonyms name NF-kappa-B inhibitor beta
Locus 19q13, 1
Discovery year 1997-07-01
GenBank acession L40407
Entrez gene record 4793
Pubmed identfication 9763672
RefSeq identity NM_002503
Classification Ankyrin repeat domain containing
Havana BLAST/BLAT OTTHUMG00000177631

Similar products

Subscribe to our Newsletter